Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects

Journal of Alzheimer's Disease

Volumn 32, Issue 4, 2012, Pages 969-979

  Mattila, Jussi ^a   Soininen, Hilkka ^b   Koikkalainen, Juha ^a   Rueckert, Daniel ^c   Wolz, Robin ^c   Waldemar, Gunhild ^d   Lötjönen, Jyrki ^a  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d University of Copenhagen   (Denmark)

Author keywords

Clinical decision support; early Alzheimer's disease; mild cognitive impairment; patient selection

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; DISEASE STATE INDEX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MILD COGNITIVE IMPAIRMENT; PREDICTION; PRIORITY JOURNAL;

EID: 84872330132     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120934     Document Type: Article

References (37)

1. Morris JC (2005) Early-stage and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord 19, 163-165.
2. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr (2009) Mild cognitive impairment: Ten years later. Arch Neurol 66, 1447-1455.
3. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, Barberger-Gateau P, Dartigues JF (2002) Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 59, 1594-1599.
4. Ganguli M, Snitz BE, Saxton JA, Chang CC, Lee CW, Vander Bilt J, Hughes TF, Loewenstein DA, Unverzagt FW, Petersen RC (2011) Outcomes of mild cognitive impairment by definition: A population study. Arch Neurol 68, 761-767.
5. Cattel C, Gambassi G, Sgadari A, Zuccal̀a G, Carbonin P, Bernabei R (2000) Correlates of delayed referral for the diagnosis of dementia in an outpatient population. J Gerontol A Biol Sci Med Sci 55, M98-M102.
6. Fiske A, Gatz M, Aadnøy B, Pedersen NL (2005) Assessing age of dementia onset: Validity of informant reports. Alzheimer Dis Assoc Disord 19, 128-134.
7. Speechly CM, Bridges-Webb C, Passmore E (2008) The pathway to dementia diagnosis. MJA 189, 487-489.
8. Bond J, Stave C, Sganga A, Vincenzino O, O'Connell B, Stanley R (2005) Inequalities in dementia care across Europe:Key findings of the Facing Dementia Survey. Int J Clin Pract 59, 8-14.
9. Ramakers IH, Visser PJ, Aalten P, Boesten JH, Metsemakers JF, Jolles J, Verhey FR (2007) Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis. Dement Geriatr Cogn Disord 24, 300-306.
10. Duara R, Barker W, Loewenstein D, Bain L (2009) The basis for disease-modifying treatments for Alzheimer's disease: The sixth annual mild cognitive impairment symposium. Alzheimers Dement 5, 66-74.
11. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
12. Lim A, Tsuang D, Kukull W, Nochlin D, Leverenz J, McCormick W, Bowen J, Teri L, Thompson J, Peskind ER, Raskind M, Larson EB (1999) Clinico- neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc 47, 564-569.
13. Petrovitch H, White LR, Ross GW, Steinhorn SC, Li CY, Masaki KH, Davis DG, Nelson J, Hardman J, Curb JD, Blanchette PL, Launer LJ, Yano K, Markesbery WR (2001) Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology 57, 226-234.
14. Kazee AM, Eskin TA, Lapham LW, Gabriel KR, McDaniel KD, Hamill RW (1993) Clinicopathologic correlates in Alzheimer disease: Assessment of clinical and pathologic diagnostic criteria. Alzheimer Dis Assoc Disord 7, 152-164.
15. Jacobs HI, Van Boxtel MP, van der Elst W, Burgmans S, Smeets F, Gronenschild EH, Verhey FR, Uylings HB, Jolles J (2011) Increasing the diagnostic accuracy of medial temporal lobe atrophy in Alzheimer's disease. J Alzheimers Dis 25, 477-490.
16. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rośen E, Aarsland D, Visser PJ, Schr̈oder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttil̈a T, Wallin A, J̈onhagen ME, Minthon L, Winblad B, Blennow K (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA302, 385-393.
17. Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L'italien G, van der Flier W, Aalten P, Teunissen C, Barkhof F, Blennow K, Wolz R, Rueckert D, Verhey F, Visser PJ (2012) Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging 33, 2272-2281.
18. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746.
19. Clifford JR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 257-262.
20. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
21. Misra C, Fan Y, Davatzikos C (2008) Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI. Neuroimage 44, 1415-1422.
22. Hinrichs C, Singh V, Xu G, Johnson SC, Alzheimers Disease Neuroimaging Initiative (2011) Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population. NeuroImage 55, 574-589.
23. Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ (2011) Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 32, 2322. e19-27.
24. Llano DA, Laforet G, Devanarayan V (2011) Derivation of a newADAS-cog composite using tree-based multivariate analysis: Prediction of conversion from mild cognitive impairment to Alzheimer disease. Alz Dis Assoc Dis 25, 73-84.
25. Clifford JR Jr, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC (2005) Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65, 1227-1231.
26. Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, Terzi A, Vignolo LA, Di Luca M, Giubbini R, Padovani A, Perani D (2006) Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 27, 24-31.
27. Toledo-Morrell L, Stoub TR, Bulgakova M, Wilson RS, Bennett DA, Leurgans S, Wuu J, Turner DA (2004) MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 25, 1197-1203.
28. Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; AddNeuroMed consortium; Alzheimer's Disease Neuroimaging Initiative (2011) AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. NeuroImage 58, 818-828.
29. Tondelli M, Wilcock GK, Nichelli P, De Jager CA, Jenkinson M, Zamboni G (2012) Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol Aging 33, e825-e836.
30. Mattila J, Koikkalainen J, Virkki A, Simonsen A, van Gils M, Waldemar G, Soininen H, L̈otj̈onen J; Alzheimer's Disease Neuroimaging Initiative (2011) A disease state fingerprint for evaluation of Alzheimer's disease. J Alzheimers 27, 163-176.
31. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L (2005) The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am 15, 869-877.
32. Mattila J, Koikkalainen J, Virkki A, van Gils M, L̈otj̈onen J, Alzheimer's Disease Neuroimaging Initiative (2012) Design and application of a generic clinical decision support system for multiscale data. IEEE Trans Biomed Eng 59, 234-240.
33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
34. Ashburner J, Friston KJ (2000) Voxel-based morphometry-the methods. NeuroImage 11, 805-821.
35. Koikkalainen J, L̈otj̈onen J, Thurfjell L, Rueckert D, Waldemar G, Soininen H (2011) The Alzheimer's Disease Neuroimaging Initiative. Multi-template tensor-based morphometry: Application to analysis of Alzheimer's disease. NeuroImage 56, 1134-1144.
36. L̈otj̈onen J, Wolz R, Koikkalainen J, Julkunen V, Thurfjell L, Lundqvist R, Waldemar G, Soininen H, Rueckert D; The Alzheimer's Disease Neuroimaging Initiative (2011) Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease. NeuroImage 56, 185-196.
37. Koikkalainen J, P̈ol̈onen H, Mattila J, van Gils M, Soininen H, L̈otj̈onen J; Alzheimer's Disease Neuroimaging Initiative (2012) Improved classification of Alzheimer's disease data via removal of nuisance variability. PLoS One 7, e31112.